Compare BMEA & SFBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BMEA | SFBC |
|---|---|---|
| Founded | 2017 | 1953 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.2M | 103.8M |
| IPO Year | 2021 | 2012 |
| Metric | BMEA | SFBC |
|---|---|---|
| Price | $1.73 | $46.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $9.83 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 14.3K |
| Earning Date | 05-12-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 2.04% |
| EPS Growth | ★ 69.19 | 53.89 |
| EPS | N/A | ★ 1.59 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $29.76 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.87 | $40.68 |
| 52 Week High | $2.99 | $49.21 |
| Indicator | BMEA | SFBC |
|---|---|---|
| Relative Strength Index (RSI) | 75.92 | 57.43 |
| Support Level | $1.23 | $41.29 |
| Resistance Level | $1.69 | $48.04 |
| Average True Range (ATR) | 0.11 | 0.57 |
| MACD | 0.04 | -0.02 |
| Stochastic Oscillator | 72.03 | 75.88 |
Biomea Fusion Inc is a a clinical stage diabetes and obesity medicines company focused on the discovery and development of oral, small molecule drugs to treat and improve the lives of patients with diabetes, obesity, and other metabolic diseases. It operate as an organization centered on two of its core drug candidate development programs: (i) icovamenib, its clinical program's drug candidate, currently being developed as an orally bioavailable, and selective, covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity, and (ii) BMF-650, its investigational, next-generation oral glucagon-like peptide-1 GLP-1 receptor agonist in development for the treatment of obesity.
Sound Financial Bancorp Inc operates as the holding company for Sound Community Bank that provides traditional banking and other financial services for individuals and businesses. It attracts retail and commercial deposits from the public and invests those funds, along with borrowed funds, in loans secured by first and second mortgages on one-to-four-family residences including home equity loans and lines of credit, commercial and multifamily real estate, construction and land, consumer and commercial business loans. The bank also offers secured and unsecured consumer loan products, including manufactured home loans, floating home loans, automobile loans, boat loans, and recreational vehicle loans.